Literature DB >> 16831609

NADPH oxidase in the liver: defensive, offensive, or fibrogenic?

Samuele De Minicis1, Ramón Bataller, David A Brenner.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16831609     DOI： 10.1053/j.gastro.2006.05.048

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  39 in total

1.  Deletion of platelet-derived growth factor receptor-β improves diabetic nephropathy in Ca²⁺/calmodulin-dependent protein kinase IIα (Thr286Asp) transgenic mice.

Authors:  H Suzuki; I Usui; I Kato; T Oya; Y Kanatani; Y Yamazaki; S Fujisaka; S Senda; Y Ishii; M Urakaze; A Mahmood; S Takasawa; H Okamoto; M Kobayashi; K Tobe; M Sasahara
Journal:  Diabetologia       Date:  2011-08-11       Impact factor: 10.122

Review 2.  Inflammation and fibrogenesis in steatohepatitis.

Authors:  Hideki Fujii; Norifumi Kawada
Journal:  J Gastroenterol       Date:  2012-02-07       Impact factor: 7.527

3.  The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88.

Authors:  Istvan Hritz; Pranoti Mandrekar; Arumugam Velayudham; Donna Catalano; Angela Dolganiuc; Karen Kodys; Evelyn Kurt-Jones; Gyongyi Szabo
Journal:  Hepatology       Date:  2008-10       Impact factor: 17.425

Review 4.  Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches.

Authors:  Elisabetta Mormone; Joseph George; Natalia Nieto
Journal:  Chem Biol Interact       Date:  2011-07-22       Impact factor: 5.192

5.  The presence of p47phox in liver parenchymal cells is a key mediator in the pathogenesis of alcoholic liver steatosis.

Authors:  Ivan Levin; Jan Petrasek; Gyongyi Szabo
Journal:  Alcohol Clin Exp Res       Date:  2012-02-29       Impact factor: 3.455

6.  Loss of c-Met accelerates development of liver fibrosis in response to CCl(4) exposure through deregulation of multiple molecular pathways.

Authors:  Jens U Marquardt; Daekwan Seo; Luis E Gómez-Quiroz; Koichi Uchida; Matthew C Gillen; Mitsuteru Kitade; Pal Kaposi-Novak; Elizabeth A Conner; Valentina M Factor; Snorri S Thorgeirsson
Journal:  Biochim Biophys Acta       Date:  2012-02-22

Review 7.  Role of NADPH oxidases in liver fibrosis.

Authors:  Yong-Han Paik; Jonghwa Kim; Tomonori Aoyama; Samuele De Minicis; Ramon Bataller; David A Brenner
Journal:  Antioxid Redox Signal       Date:  2014-01-24       Impact factor: 8.401

8.  Reversal of liver fibrosis.

Authors:  Mona H Ismail; Massimo Pinzani
Journal:  Saudi J Gastroenterol       Date:  2009-01       Impact factor: 2.485

9.  Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C.

Authors:  Jordi Colmenero; Ramón Bataller; Pau Sancho-Bru; Marlene Domínguez; Montserrat Moreno; Xavier Forns; Miquel Bruguera; Vicente Arroyo; David A Brenner; Pere Ginès
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-07-23       Impact factor: 4.052

10.  Hepatic wound repair.

Authors:  Maurizio Parola; Massimo Pinzani
Journal:  Fibrogenesis Tissue Repair       Date:  2009-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.